Disease Control and Prevention Vaccine Market
Global Disease Control and Prevention Vaccine Market Size, Share & Trends Analysis Report By Type (Live-Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Toxoid Vaccine, Others), and By Indication (Infectious Disease, Cancer, and Other Indication) Forecast 2022-2028 Update Available - Forecast 2024-2030
The global disease control and prevention vaccine market is anticipated to grow at a significant CAGR of 12.1% during the forecast period. The global market is growing due to the high prevalence and increasing incidence of the disease. As per the information provided by the US Department of Health & Human Services in 2021, around 146.6 million people in the US were anticipated to be affected by Infections. Additionally, government and NGO’s working together to provide better immunization to the population suffering from diseases is boosting the market growth. For instance, the Global Polio Eradication Initiative is a public-private partnership initiative by five governmental organizations that include WHO, Rotary International, CDC, UNICEF, and the Bill & Melinda Gates Foundation focusing on polio eradication across the globe. Additionally, the US FDA, CDC, and NIH have partnered with the US Department of Health and Human Services Biomedical Advanced Research and Development Authority for the research and development of new vaccines which is also driving the market growth. However, the high cost of vaccination is considered a restraining factor for the global disease control and prevention vaccine market to grow in the forecast period.
Impact of COVID-19 Pandemic on Global Disease control and prevention vaccine Market
During the COVID-19 Pandemic, the demand for vaccines in the global disease control and prevention vaccine market has substantially increased as all the major market players globally were focused on the research and development of COVID-19 vaccines. Additionally, other vaccines and research were in the pipeline and the major focus was on the development and mass production of COVID-19 vaccines as it was considered the most important vaccine that the population needs at this stage.
Segmental Outlook
The global disease control and prevention vaccine market is segmented based on the type and indication. Based on the type, the market is segmented into a live-attenuated vaccine, inactivated vaccine, subunit vaccine, toxoid vaccine, and others. Amongst the type, the live-attenuated vaccine is anticipated to propel the growth of the market over the forecast period. Further, based on the indication, the market is sub-segmented into infectious disease, cancer, and others indication.
Global Disease Control and Prevention Vaccine Market Share by Type, 2022 (%)
The Live-Attenuated Vaccine is anticipated to Hold a Prominent Share in the Global Disease Control and Prevention Vaccine Market
The live-attenuated vaccine market is anticipated to hold a significant share in the global disease control and prevention vaccine market. This vaccine introduces actual live pathogens into the body and is considered as a finest simulation for the health system. Live-attenuated vaccines gives output in life long immunity with just one or two doses. Additionally, the advancement in the field of medical treatment and technology for the development of medicine and novel vaccine will result in the growth of the recombinant and subunit vaccines globally.
Regional Outlooks
The global disease control and prevention vaccine market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The North American disease control and prevention vaccine market is expected to hold prominent share in the global disease control and prevention vaccine market.
Global Disease Control and Prevention Vaccine Market Growth, by Region 2022-2028
The North America Region is estimated to Hold the Major Share in the Global Disease Control and Prevention Vaccine Market
North America is anticipated to hold a significant share in the global disease control and prevention vaccine market. This is due to the increased adoption and awareness of disease control and prevention vaccines among the population and well- developed healthcare infrastructure in this region. In US, the CDC Advisory Committee for Immunization Practices regularly publishes recommendations for vaccines and carries out different awareness programs to aware the population.
Market Players Outlook
The major companies serving the global disease control and prevention vaccine market include AstraZeneca, Astellas Pharma Inc., Blistex Inc., Church & Dwight Co., Inc., Serum Institute of India Pvt. Ltd., and many more. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new vaccine launches for the advancement of the disease treatment, to stay competitive in the market. For instance, in January 2022, Pfizer, Inc., and BioNtech announced the initiation of a clinical study to evaluate the safety, tolerability, and immunogenicity of an Omicron-based vaccine in healthy adults 18 through 55 years of age
The Report Covers
- Market value data analysis of 2022 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global disease control and prevention vaccine market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on The Global Disease Control and Prevention Vaccine Market
• Recovery Scenario of Global Disease Control and Prevention Vaccine Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. AstraZeneca
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Astellas Pharma Inc.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Blistex Inc.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Church & Dwight Co., Inc.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Serum Institute of India Pvt. Ltd.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Disease Control and Prevention Vaccine Market by Type
4.1.1. Live-Attenuated Vaccine
4.1.2. Inactivated Vaccine
4.1.3. Subunit Vaccine
4.1.4. Toxoid Vaccine
4.1.5. Others
4.2. Global Disease Control and Prevention Vaccine Market by Indication
4.2.1. Infectious Disease
4.2.2. Cancer
4.2.3. Other Indication
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. 3M
6.2. Bristol-Myers Squibb Co.
6.3. Colgate-Palmolive Co.
6.4. Daiichi Sankyo Co. Ltd.
6.5. Emergent BioSolutions Inc.EMERGENT
6.6. GlaxoSmithKline Plc.
6.7. Johnson & Johnson Services Inc.
6.8. Merck & Co., Inc.
6.9. Pfizer Inc.
6.10. Sanofi
6.11. Sinovac Biotech Ltd.SIVONAC
6.12. VBI Vaccines Inc.
1. GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL LIVE-ATTENUATED VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL INACTIVATED VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL SUBUNIT VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL TOXOID VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL OTHERS VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY INDICATION, 2021-2028 ($ MILLION)
8. GLOBAL INFECTIOUS DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL CANCER DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL OTHERS DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
12. NORTH AMERICAN DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
13. NORTH AMERICAN DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
14. NORTH AMERICAN DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY INDICATION, 2021-2028 ($ MILLION)
15. EUROPEAN DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
16. EUROPEAN DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
17. EUROPEAN DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY INDICATION, 2021-2028 ($ MILLION)
18. ASIA-PACIFIC DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19. ASIA-PACIFIC DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
20. ASIA-PACIFIC DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY INDICATION, 2021-2028 ($ MILLION)
21. REST OF THE WORLD DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
22. REST OF THE WORLD DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
23. REST OF THE WORLD DISEASE CONTROL AND PREVENTION VACCINE MARKET RESEARCH AND ANALYSIS BY INDICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET, 2022-2028 (%)
4. GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL LIVE-ATTENUATED VACCINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL INACTIVATED VACCINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL SUBUNIT VACCINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL TOXOID VACCINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL OTHERS VACCINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET SHARE BY INDICATION, 2021 VS 2028 (%)
11. GLOBAL INFECTIOUS DISEASE CONTROL AND PREVENTION VACCINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL CANCER DISEASE CONTROL AND PREVENTION VACCINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL OTHERS INDICATION DISEASE CONTROL AND PREVENTION VACCINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL DISEASE CONTROL AND PREVENTION VACCINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. US DISEASE CONTROL AND PREVENTION VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
16. CANADA DISEASE CONTROL AND PREVENTION VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
17. UK DISEASE CONTROL AND PREVENTION VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
18. FRANCE DISEASE CONTROL AND PREVENTION VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
19. GERMANY DISEASE CONTROL AND PREVENTION VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
20. ITALY DISEASE CONTROL AND PREVENTION VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
21. SPAIN DISEASE CONTROL AND PREVENTION VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
22. REST OF EUROPE DISEASE CONTROL AND PREVENTION VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
23. INDIA DISEASE CONTROL AND PREVENTION VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
24. CHINA DISEASE CONTROL AND PREVENTION VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
25. JAPAN DISEASE CONTROL AND PREVENTION VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
26. REST OF ASIA-PACIFIC DISEASE CONTROL AND PREVENTION VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
27. REST OF THE WORLD DISEASE CONTROL AND PREVENTION VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
